DD298391A5 - Verfahren zur herstellung von pyridinderivaten - Google Patents

Verfahren zur herstellung von pyridinderivaten Download PDF

Info

Publication number
DD298391A5
DD298391A5 DD90339534A DD33953490A DD298391A5 DD 298391 A5 DD298391 A5 DD 298391A5 DD 90339534 A DD90339534 A DD 90339534A DD 33953490 A DD33953490 A DD 33953490A DD 298391 A5 DD298391 A5 DD 298391A5
Authority
DD
German Democratic Republic
Prior art keywords
tetrahydro
lower alkyl
group
aryl
quinoline
Prior art date
Application number
DD90339534A
Other languages
German (de)
English (en)
Inventor
Ian A Cliffe
Alan C White
Howard L Mansell
Richard S Todd
Original Assignee
�����@��������@�K@�����������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@��������@�K@�����������@�������k�� filed Critical �����@��������@�K@�����������@�������k��
Publication of DD298391A5 publication Critical patent/DD298391A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD90339534A 1989-04-07 1990-04-06 Verfahren zur herstellung von pyridinderivaten DD298391A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898907865A GB8907865D0 (en) 1989-04-07 1989-04-07 Tetrahydroquinoline derivatives

Publications (1)

Publication Number Publication Date
DD298391A5 true DD298391A5 (de) 1992-02-20

Family

ID=10654625

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90339534A DD298391A5 (de) 1989-04-07 1990-04-06 Verfahren zur herstellung von pyridinderivaten

Country Status (22)

Country Link
US (1) US5075303A (da)
EP (1) EP0395244B1 (da)
JP (1) JP2945064B2 (da)
KR (1) KR0156569B1 (da)
AT (1) ATE149031T1 (da)
AU (1) AU625845B2 (da)
CA (1) CA2014062C (da)
DD (1) DD298391A5 (da)
DE (1) DE69029954T2 (da)
DK (1) DK0395244T3 (da)
ES (1) ES2099703T3 (da)
FI (1) FI95373C (da)
GB (2) GB8907865D0 (da)
GR (1) GR3023396T3 (da)
HK (1) HK121994A (da)
HU (1) HU217128B (da)
IE (1) IE63627B1 (da)
IL (1) IL94011A (da)
NZ (1) NZ233222A (da)
PH (1) PH27590A (da)
PT (1) PT93673B (da)
ZA (1) ZA902662B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273994A (en) * 1990-04-09 1993-12-28 Adir Et Compagnie 3-aminochroman compounds
FR2660657B1 (fr) * 1990-04-09 1993-05-07 Adir Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9019942D0 (en) * 1990-09-12 1990-10-24 Wyeth John & Brother Ltd Azetidine derivatives
US5532243A (en) * 1992-02-14 1996-07-02 The Dupont Merck Pharmaceutical Company Antipsychotic nitrogen-containing bicyclic compounds
GB9304632D0 (en) * 1993-03-06 1993-04-21 Wyeth John & Brother Ltd Amide derivatives
AU1599395A (en) * 1994-01-03 1995-08-01 Cocensys, Inc. 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
US6180632B1 (en) * 1997-05-28 2001-01-30 Aventis Pharmaceuticals Products Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
US7105513B2 (en) * 2002-08-07 2006-09-12 Sanofi-Avertis Deutschland Gmbh Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
KR20110130487A (ko) * 2009-03-23 2011-12-05 시플라 리미티드 독사조신 및 그의 염의 제조방법
AU2012327076B2 (en) * 2011-10-18 2017-07-06 Astellas Pharma Inc. Bicyclic heterocyclic compound
WO2015153813A1 (en) * 2014-04-01 2015-10-08 Howard Hughes Medical Institute Azetidine-substituted fluorescent compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH566315A5 (da) * 1972-04-04 1975-09-15 Ciba Geigy Ag
GB1463582A (en) * 1974-03-05 1977-02-02 Wyeth John & Brother Ltd Pyridine derivatives
GB1463583A (en) * 1974-03-05 1977-02-02 Wyeth John & Brother Ltd Halo and hydroxy compounds
DK309678A (da) * 1977-07-18 1979-01-19 Sandoz Ag Fremgangsmaade til fremstilling af tetralinderivater
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
JPS63107990A (ja) * 1986-05-14 1988-05-12 Nippon Shinyaku Co Ltd キノリンカルボン酸誘導体
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
US4894084A (en) * 1987-12-29 1990-01-16 Fmc Corporation Substituted quinolinonyl and dihydroquinolinonyl triazolinone herbicides
US4878941A (en) * 1987-12-29 1989-11-07 Fmc Corporation Herbicides

Also Published As

Publication number Publication date
AU625845B2 (en) 1992-07-16
GB8907865D0 (en) 1989-05-24
KR900016138A (ko) 1990-11-12
FI901761A0 (fi) 1990-04-06
GB2230007A (en) 1990-10-10
HUT54658A (en) 1991-03-28
NZ233222A (en) 1991-07-26
DE69029954T2 (de) 1997-05-28
PT93673B (pt) 1996-08-30
AU5297190A (en) 1990-10-11
IE63627B1 (en) 1995-05-17
DE69029954D1 (de) 1997-03-27
EP0395244B1 (en) 1997-02-19
ZA902662B (en) 1991-02-27
GB2230007B (en) 1992-10-14
ATE149031T1 (de) 1997-03-15
HU902108D0 (en) 1990-08-28
DK0395244T3 (da) 1997-03-17
IL94011A (en) 1994-06-24
GB9007889D0 (en) 1990-06-06
HU217128B (hu) 1999-11-29
GR3023396T3 (en) 1997-08-29
FI95373B (fi) 1995-10-13
FI95373C (fi) 1996-01-25
EP0395244A1 (en) 1990-10-31
CA2014062A1 (en) 1990-10-07
JPH02290852A (ja) 1990-11-30
PT93673A (pt) 1990-11-20
US5075303A (en) 1991-12-24
HK121994A (en) 1994-11-11
ES2099703T3 (es) 1997-06-01
KR0156569B1 (ko) 1998-11-16
PH27590A (en) 1993-08-18
CA2014062C (en) 2000-06-13
JP2945064B2 (ja) 1999-09-06

Similar Documents

Publication Publication Date Title
EP0861236B2 (de) Cyclische und heterocyclische n-substituierte alpha-iminohydroxam- und carbonsäuren
DE60104776T2 (de) Diphenylharnstoffderivate und deren Verwendung als alpha2/5-HT2c Antagonisten
DD209622A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
EP0136658A2 (de) 1-Benzyl-aminoalkyl-pyrrolidinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
EP0013894B1 (de) Neue Arylether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DD298391A5 (de) Verfahren zur herstellung von pyridinderivaten
EP0271795A2 (de) Octahydro-10-oxo-6H-pyridazo [1,2-a] [1,2] diazepin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
EP0387618B1 (de) 1,7-anellierte 1H-Indol-2-carbonsäure-N-(1,4-benzodiazepin-3-yl)amide
DE60011916T2 (de) Heteroaryloxypropanolamine als beta3-adrenergischer rezeptor-agonisten
DE60225195T2 (de) Flavaxat-derivate als muscarin-rezeptor antagonisten
DE3856501T2 (de) Schlafverbesserungsmittel
WO2001070687A1 (de) Indole zur behandlung von krankheiten die mit schilddrüsenhormonen behandeln werden können
EP0802195A2 (de) Substituierte 2,3-Benzodiazepinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate sowie ihre Verwendung
DE60200089T2 (de) Octahydro-2H-pyrido[1,2-a]pyrazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0548664B1 (de) 2,3,3a,4,5,9b-Hexahydro-1H-benzo[e]indol-Derivate
DE2719294A1 (de) Neue derivate des 1,4-benzodioxans, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE2841126C2 (da)
EP0266308B1 (de) Indolo-pyrazino-benzodiazepin-Derivate
DE69827614T2 (de) Chinoxalindionen
EP0491243B1 (de) Alkylaminoalkylamin- und -äther- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0508370B1 (de) Kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel zur Behandlung von Erkrankungen des Zentralnervensystems und zur Förderung der cerebralen Durchblutung
DE60033060T2 (de) Lineare oder zyklische Harnstoffe, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE69907636T2 (de) 2-aminochinolinderivate mit d4-agonistischer wirkung
EP0239667B1 (de) 5- oder 6-substituierte-beta-carbolin-3-carbonsäureester
EP0301245B1 (de) 3-Sulfonyl-3,7-diazabicyclo-(3,3,1)nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20100407